€5.73
0.42% today
L&S, Jun 27, 11:54 am CET
ISIN
US7458481014
Symbol
LUNG

ProLung Inc Share price

$6.14
-1.93 23.92% 1M
-6.82 52.62% 6M
-6.61 51.84% YTD
-6.73 52.29% 1Y
-38.90 86.37% 3Y
-12.86 67.68% 5Y
-12.86 67.68% 10Y
Nasdaq, Closing price Wed, Jun 26 2024
ISIN
US7458481014
Symbol
LUNG
Sector

Key figures

Market capitalization $238.33m
Enterprise Value $162.53m
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.23
P/S ratio (TTM) P/S ratio 3.27
P/B ratio (TTM) P/B ratio 2.16
Sales growth (TTM) Sales growth 27.14%
Turnover (TTM) Turnover $72.99m
EBIT (operating result TTM) EBIT $-60.07m
Free cash flow (TTM) Free cash flow $-37.96m
Cash position $116.37m
EPS (TTM) EPS $-1.54
P/E ratio expected negative
P/S ratio expected 2.89
EV/Sales expected 1.97
Short interest 5.72%
Show more

Is ProLung Inc a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,947 shares worldwide.

ProLung Inc Share analysis

Unlock scores for free

Analyst opinions

6 Analysts have issued a ProLung Inc forecast:

5x Buy
83%
1x Hold
17%

Analyst opinions

6 Analysts have issued a ProLung Inc forecast:

Buy
83%
Hold
17%

Financial data from ProLung Inc

Profit and loss account P&L | Balance sheet | Cash flow


Quarter TTM Annually
Mar '24
+/-
%
73 73
27% 27%
100%
- Direct costs 19 19
25% 25%
26%
54 54
28% 28%
74%
- Selling and administrative expenses 94 94
15% 15%
128%
- Research and development costs 18 18
12% 12%
25%
-58 -58
4% 4%
-79%
- Depreciation and amortization 2.40 2.40
40% 40%
3%
EBIT (operating result) EBIT -60 -60
1% 1%
-82%
Net profit -59 -59
0% 0%
-80%

Figures in millions USD.

Don't miss a thing! We will send you all news about the ProLung Inc share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

ProLung Inc Share News

Neutral
GlobeNewsWire
about 2 months ago
REDWOOD CITY, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that the Compensation Committee of the Board of Directors of Pulmonx (the “Compensation Committee”) granted inducement awards consisting of a non-statutory stock option to purchase 241,409 share...
Neutral
Seeking Alpha
about 2 months ago
Pulmonx Corporation (NASDAQ:LUNG ) Q1 2024 Earnings Call Transcript May 1, 2024 4:30 PM ET Company Participants Elizabeth Sparicio - Investor Relations at the Gilmartin Group Steve Williamson - President & Chief Executive Officer Mehul Joshi - Chief Financial Officer Conference Call Participants Jon Young - Canaccord Rick Wise - Stifel Vik Chopra - Wells Fargo Operator Good day, and thank you f...
Neutral
GlobeNewsWire
about 2 months ago
REDWOOD CITY, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the “Company”), a global leader in minimally invasive treatments for lung disease, today reported financial results for the quarter ended March 31, 2024.
More ProLung Inc News

Company profile

Pulmonx Corp. provides interventional pulmonology, planning tools, and treatments for obstructive lung diseases. It carries out its operations in the following geographical locations: Europe, Middle East and Africa (EMEA), Asia Pacific, Other International, and United States. It offers the Zephyr Endobronchial Valve, an implantable device used to occlude all airways feeding the hyperinflated lobe of a lung that is most diseased with emphysema. It also offers StratX Lung Analysis, a platform designed to treat severe emphysema, and the Chartis Assessment System, a pulmonary assessment system. The company was founded by Rodney C. Perkins and is headquartered in Redwood City, CA.

Head office United States
CEO Steven Williamson
Employees 279
Founded 1995
Website www.pulmonx.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now